166 related articles for article (PubMed ID: 29920533)
1. Influence of lifestyle and genetic variants in the aldo-keto reductase 1C3 rs12529 polymorphism in high-risk prostate cancer detection variability assessed between US and New Zealand cohorts.
Karunasinghe N; Ambs S; Wang A; Tang W; Zhu S; Dorsey TH; Goudie M; Masters JG; Ferguson LR
PLoS One; 2018; 13(6):e0199122. PubMed ID: 29920533
[TBL] [Abstract][Full Text] [Related]
2. Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand.
Karunasinghe N; Symes E; Gamage A; Wang A; Murray P; Zhu S; Goudie M; Masters J; Ferguson LR
PLoS One; 2019; 14(5):e0217373. PubMed ID: 31125365
[TBL] [Abstract][Full Text] [Related]
3. Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions.
Karunasinghe N; Minas TZ; Bao BY; Lee A; Wang A; Zhu S; Masters J; Goudie M; Huang SP; Jenkins FJ; Ferguson LR
Sci Rep; 2022 Jan; 12(1):55. PubMed ID: 34997089
[TBL] [Abstract][Full Text] [Related]
4. Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?
Karunasinghe N; Zhu Y; Han DY; Lange K; Zhu S; Wang A; Ellett S; Masters J; Goudie M; Keogh J; Benjamin B; Holmes M; Ferguson LR
BMC Urol; 2016 Aug; 16(1):48. PubMed ID: 27485119
[TBL] [Abstract][Full Text] [Related]
5. Influence of Aldo-keto Reductase 1C3 in Prostate Cancer - A Mini Review.
Karunasinghe N; Masters J; Flanagan JU; Ferguson LR
Curr Cancer Drug Targets; 2017; 17(7):603-616. PubMed ID: 28359237
[TBL] [Abstract][Full Text] [Related]
6. Genetically adjusted prostate-specific antigen values may prevent delayed biopsies in African-American men.
Donin NM; Loeb S; Cooper PR; Roehl KA; Baumann NA; Catalona WJ; Helfand BT
BJU Int; 2014 Dec; 114(6b):E50-E55. PubMed ID: 24712975
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory Interplay of SULT2B1b Sulfotransferase with AKR1C3 Aldo-keto Reductase in Prostate Cancer.
Park S; Song CS; Lin CL; Jiang S; Osmulski PA; Wang CM; Marck BT; Matsumoto AM; Morrissey C; Gaczynska ME; Chen Y; Mostaghel EA; Chatterjee B
Endocrinology; 2020 Feb; 161(2):. PubMed ID: 31894239
[TBL] [Abstract][Full Text] [Related]
8. Influence of aldo-keto reductase 1C3 polymorphisms in early-onset female psoriasis patients.
Nojiri Y; Nakamura M; Magara T; Yamamoto A; Ikumi K; Nakamura R; Nishida E; Haarmann-Stemmann T; Morita A
Sci Rep; 2023 Feb; 13(1):3280. PubMed ID: 36841845
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
[TBL] [Abstract][Full Text] [Related]
10. Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid.
Pippione AC; Carnovale IM; Bonanni D; Sini M; Goyal P; Marini E; Pors K; Adinolfi S; Zonari D; Festuccia C; Wahlgren WY; Friemann R; Bagnati R; Boschi D; Oliaro-Bosso S; Lolli ML
Eur J Med Chem; 2018 Apr; 150():930-945. PubMed ID: 29602039
[TBL] [Abstract][Full Text] [Related]
11. AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression.
Tian Y; Zhao L; Zhang H; Liu X; Zhao L; Zhao X; Li Y; Li J
Diagn Pathol; 2014 Feb; 9():42. PubMed ID: 24571686
[TBL] [Abstract][Full Text] [Related]
12. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
[TBL] [Abstract][Full Text] [Related]
13. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.
Cross CK; Shultz D; Malkowicz SB; Huang WC; Whittington R; Tomaszewski JE; Renshaw AA; Richie JP; D'Amico AV
J Clin Oncol; 2002 Jun; 20(12):2863-8. PubMed ID: 12065563
[TBL] [Abstract][Full Text] [Related]
14. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
[TBL] [Abstract][Full Text] [Related]
15. Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer.
Chang BL; Hughes L; Chen DY; Gross L; Ruth K; Giri VN
BJU Int; 2014 May; 113(5b):E150-6. PubMed ID: 23937305
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel epithelial ovarian cancer loci in women of African ancestry.
Manichaikul A; Peres LC; Wang XQ; Barnard ME; Chyn D; Sheng X; Du Z; Tyrer J; Dennis J; Schwartz AG; Cote ML; Peters E; Moorman PG; Bondy M; Barnholtz-Sloan JS; Terry P; Alberg AJ; Bandera EV; Funkhouser E; Wu AH; Pearce CL; Pike M; Setiawan VW; Haiman CA; ; ; Palmer JR; LeMarchand L; Wilkens LR; Berchuck A; Doherty JA; Modugno F; Ness R; Moysich K; Karlan BY; Whittemore AS; McGuire V; Sieh W; Lawrenson K; Gayther S; Sellers TA; Pharoah P; Schildkraut JM;
Int J Cancer; 2020 Jun; 146(11):2987-2998. PubMed ID: 31469419
[TBL] [Abstract][Full Text] [Related]
17. Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection.
Hughes L; Zhu F; Ross E; Gross L; Uzzo RG; Chen DY; Viterbo R; Rebbeck TR; Giri VN
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):53-60. PubMed ID: 22144497
[TBL] [Abstract][Full Text] [Related]
18. Rates of clinically significant prostate cancer in African Americans increased significantly following the 2012 US Preventative Services Task Force recommendation against prostate specific antigen screening: A Single Institution Retrospective Study.
Arace J; Flores V; Monaghan T; Robins D; Karanikolas N; Winer A; Weiss J
Int J Clin Pract; 2020 Feb; 74(2):e13447. PubMed ID: 31750596
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Evaluation of the Reductase Activities of Human
Takano S; Fukami T; Ichida H; Suzuki K; Nakano M; Nakajima M
Drug Metab Dispos; 2023 Sep; 51(9):1188-1195. PubMed ID: 37344179
[TBL] [Abstract][Full Text] [Related]
20. Is prostate cancer stage migration continuing for black men in the PSA era?
Dobbs RW; Greenwald DT; Wadhwa H; Freeman VL; Abern MR
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):210-215. PubMed ID: 28094251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
